SCHEMBL7270862

SCHEMBL7270862

O=C1/C(=N\O)CCc2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.70
CYP1A2 P05177 1/20 0.70
CYP2C19 P33261 1/20 0.70
CES1 P23141 2/20 0.63
L3MBTL1 Q9Y468 3/20 0.56
HPGD P15428 2/20 0.56
LMNA P02545 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 2/20 0.47
MAOA P21397 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
HTT P42858 1/20 0.46
MAOB P27338 2/20 0.46
MIF P14174 3/20 0.45
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
KMT2A Q03164 1/20 0.44
BCHE P06276 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6306459 1.00 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL696955 1.00 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL2589100 0.89 L3MBTL1 (0.68) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL2589102 0.89 L3MBTL1 (0.68) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL2733083 0.84 HPGD (0.77) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL29453066 0.84 HPGD (0.77) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL1201521 0.84 HPGD (0.77) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL1201517 0.84 HPGD (0.77) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL29417938 0.84 HPGD (0.77) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1
SCHEMBL2281246 0.82 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP2C19CES1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080115-A2 Hexahydronaphth(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them MERCK & CO. INC. (US) 1983-06-01 EP disclosed